Toksisitas Akut Dermal Senyawa Mengkudu (Morinda citrifolia L.): Literature Review
DOI:
https://doi.org/10.36312/educatoria.v6i3.1241Keywords:
Topical Safety, Morinda citrifolia, Medicinal Plant, Acute Dermal ToxicityAbstract
Noni (Morinda citrifolia L.) is a medicinal plant widely used in traditional medicine due to its various pharmacological activities, such as anti-inflammatory, antibacterial, and antioxidant properties. However, the topical use of natural products requires safety evaluation to ensure they do not cause toxic effects on the skin. This article aims to review studies regarding the acute dermal toxicity of noni compounds and to assess their safety based on the toxicological parameters employed. A systematic literature review was conducted by searching scientific databases such as PubMed, Scopus, and Google Scholar. The findings indicate that noni extracts generally exhibit low dermal toxicity and do not cause mortality or significant clinical changes in test animals at specific dosages. However, some studies have reported instances of mild, transient irritation. Thus, noni shows potential for safe development as a topical preparation, although further research is required to confirm the safety of long-term use.
Downloads
References
Anggriani, R., Laelatunisa, N., Rizky, N., & Arum, R. (2020). Daya Terima, Zat Gizi, dan Nilai Energi Roti Tawar Anti-Diabetes dengan Penambahan Sari Mengkudu (Morinda citrifolia L.). Food Technology and Halal Science Journal, 3(1), 47–56. https://doi.org/10.22219/fths.v3i1.13060
BPOM. (2024). Laporan Kinerja BPOM 2024. Jakarta: Badan Pengawas Obat dan Makanan (BPOM) RI.
Dafriani, P., Karamika, M., Anggraini, S. S., & Marlinda, R. (2020). The Potential of Noni (Morinda citrifolia) in Lowering Blood Glucose Levels in Diabetes Mellitus Patients. Bioeduscience, 4(2), 120–123. https://doi.org/10.22236/j.bes/424919
Diina, T. R., Wahyuni, I. S., & Levita, J. (2022). Toksisitas Akut Dermal Ekstrak Tanaman sebagai Bagian dalam Aspek Keamanan Obat Herbal Terstandar Topikal. Jurnal Sains Farmasi & Klinis, 9(2), 71–79. https://doi.org/10.25077/jsfk.9.2.71-79.2022
Hardani, R., Krisna, I. K. A., Hamzah, B., & Hardani, M. F. (2020). Uji Anti Jamur Ekstrak Buah Mengkudu (Morinda citrifolia L.). Jurnal IPA & Pembelajaran IPA, 4(1), 92–102. https://doi.org/10.24815/jipi.v4i1.16579
OECD. (2017). OECD Transfer Pricing Guidelines for Multinational Enterprises and Tax Administrations 2017. Paris: OECD Publishing.
Rahmatudina, F., Harjanti, R., & Widyasti, J. H. (2023). Uji Toksisitas Subkronis Ekstrak Etanol Daun Mengkudu (Morinda citrifolia L.) dengan Penetapan Kadar Kreatinin dan BUN Tikus Putih. As-Syifaa : Jurnal Farmasi, 15(2), 112–119. https://doi.org/10.56711/jifa.v15i2.1054
Rohmah, S., Erlin, E., & Rachmawati, J. (2021). Uji Ekstrak Daun Mengkudu (Morinda citrifolia L.) terhadap Zona Hambat Pertumbuhan Bakteri Escherichia coli secara In-Vitro. Bioed : Jurnal Pendidikan Biologi, 9(1), 34-39. http://dx.doi.org/10.25157/jpb.v9i1.5342
Suhendriyo, Maulindah, Y., & Yulianto, S. (2023). Studi Literatur Manfaat Buah Mengkudu (Morinda citrifolia) Sebagai Antimikroba. Jurnal Jamu Kusuma, 3(1), 15-21. https://doi.org/10.37341/jurnaljamukusuma.v3i1.56
Suwaris, I., & Saputra, S. (2020). Evaluasi Mutu Obat Tradisional Kapsul Buah Mengkudu (Morindae citrifoliae fructus). Sintesis : Jurnal Penelitian Sains, Terapan dan Analisisnya, 1(1), 16–21. https://doi.org/10.56399/jst.v1i1.2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Herman Widjaja, Aryanilo, Adylla Adawyah Haryana, Junaida Pramesti, Mario Parningotan Hutapea, Susana Jelita Lestari Tandang, Pida Khaerunisa, Raditha Dellafanny, Fulgencia Maria Amelia De Jesus Soares, & Winda Novaliani

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

